vimarsana.com

Page 29 - லிநேபேர்கேற் விரிவான புற்றுநோய் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Evidence review examines both benefits and harms for lung cancer screening

 E-Mail IMAGE:  Two large studies have now confirmed that screening can lower the chance of dying of lung cancer in high-risk people. However, people considering screening should know that a relatively small. view more  Credit: UNC Lineberger Comprehensive Cancer Center CHAPEL HILL, NC A comprehensive review by University of North Carolina researchers and colleagues of hundreds of publications, incorporating more than two dozen articles on prevention screening for lung cancer with low-dose spiral computed tomography (LDCT), shows there are both benefits and harms from screening. The review is published in JAMA on March 9, 2021. The results of the decadelong National Lung Screening Trial (NLST) showed that LDCT could detect lung cancer better than conventional X-rays in current or previous heavy smokers. Based on those results, the United States Preventive Services Task Force (USPSTF) initially recommended low-dose CT screening for people ages 55 to 80 with a 30 pa

New lung cancer screening recommendation expands access but may not address inequities

 E-Mail IMAGE:  The revised U.S. Preventive Services Task Force s recommendations are sound and based on well-conceived evidence and modeling studies, but they alone are not enough, as we have seen limited uptake. view more  Credit: UNC Lineberger Comprehensive Cancer Center CHAPEL HILL, NC Calling the U.S. Preventive Services Task Force s newly released recommendation statement to expand eligibility for annual lung cancer screening with low-dose computed tomography a step forward, UNC Lineberger Comprehensive Cancer Center researchers say future changes should address equity and implementation issues. In an editorial published in JAMA, Louise M. Henderson, PhD, professor of radiology at UNC School of Medicine, M. Patricia Rivera, MD, professor of medicine at UNC School of Medicine, and Ethan Basch, MD, MSc, the Richard M. Goldberg Distinguished Professor in Medical Oncology and chief of oncology at the UNC School of Medicine, outlined their concerns and offered p

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.